2017, Number 4
<< Back Next >>
Med Int Mex 2017; 33 (4)
Type 2 myocardial infarction with ST segment elevation
Manzur-Sandoval D, Valdez-Hernández P, Oseguera-Moguel J
Language: Spanish
References: 17
Page: 526-532
PDF size: 434.08 Kb.
ABSTRACT
Myocardial infarction (MI) is a major cause of death and disability
worldwide. Type 2 MI is secondary to an imbalance in myocardial
oxygen delivery/consumption relationship and has its own clinical
characteristics. We report the case of a patient with multiple factors
that created an imbalance in the myocardial oxygen delivery/consumption
relationship and also had significantly ST segment elevation on
the electrocardiogram and marked elevation of troponin I. All these
changes reversed with the onset of medical management of the factors
that contributed to this imbalance.
REFERENCES
Thygesen K, Alpert JS, White HD. Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. J Am Coll Cardiol 2007;50:2173-2195.
Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. Eur Heart J 2007;28:2525-2538.
Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36(3):959-969.
Newby LK, Jesse RL, Babb JD, et al. ACCF 2012 expert consensus document on practical guidelines considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation task force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2012;60:2427-63.
Alpert JS, Thygesen KA, White HD, et al. Diagnostic and therapeutic implications of type 2 myocardial infarction: review and commentary. Am J Med 2014;127:105-8.
Saaby L, Poulsen TS, Hosbond S, et al. Classification of myocardial infarction: frequency and features of type 2 myocardial infarction. Am J Med 2013;126:789-97.
Stein GY, Herscovici G, Korenfeld R, et al. Type-II myocardial infarction--patient characteristics, management and outcomes. PLoS One 2014 Jan 2;9(1):e84285.
Baron T, Hambraeus K, Sundström J, Erlinge D, Jernberg T, Lindahl B, TOTAL-AMI study group. Type 2 myocardial infarction in clinical practice. Heart 2015;101:101-106.
Javed U, Aftab W, Ambrose JA, et al. Frequency of elevated troponin I and diagnosis of acute myocardial infarction. Am J Cardiol 2009;104:9-13.
Van Waes JA, Nathoe HM, de Graaff JC, et al; the CHASE investigators. Myocardial injury after noncardiac surgery and its association with short-term mortality. Circulation 2013;127(23):2264-2271.
Cohen MC, Aretz TH. Histological analysis of coronary artery lesions in fatal post-operative myocardial infarction. Cardiovasc Pathol 1999;8:133-139.
Gualandro DM, Campos CA, Calderaro D, et al. Coronary plaque rupture in patients with myocardial infarction after noncardiac surgery: frequent and dangerous. Atherosclerosis 2012;222(1):191-195.
Babuin L, Vasile VC, Rio Perez JA, et al. Elevated cardiac troponin is an independent risk factor for short- and longterm mortality in medical intensive care unit patients. Crit Care Med 2008;36(3):759-765.
Vasile VC, Babuin L, Rio Perez JA, et al. Long-term prognostic significance of elevated cardiac troponin levels in critically ill patients with acute gastrointestinal bleeding. Crit Care Med 2009;37(1):140-147.
Vasile VC, Chai HS, Abdeldayem D, Afessa B, Jaffe AS. Elevated cardiac troponin T levels in critically ill patients with sepsis. Am J Med 2013;126:1114-21.
De Lemos JA. Increasingly sensitive assays for cardiac troponins: a review. JAMA 2013;309:2262-9.
Bonaca MP, Wiviott SD, Braunwald E, et al. American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation Universal definition of myocardial infarction classification system and the risk of cardiovascular death: observations from the TRITON-TIMI 38 trial (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction). Circulation 2012;125:577-83.